The U.S. Food and Drug Administration (FDA) will continue providing flexibility to infant formula manufacturers under certain conditions in an effort to stabilize U.S. product supplies. 

The U.S. Food and Drug Administration (FDA) will air an upcoming TechTalk Podcast episode focusing on some of the agency’s efforts under the New Era of Smarter Food Safety; specifically, the Office of Regulatory Affairs Data Exchange.

The U.S. Food and Drug Administration (FDA) has released a document that provides an overview of the agency’s ongoing efforts to advance the safety of produce imported into the U.S. 

The U.S. Food and Drug Administration (FDA) has announced two new food safety prevention strategies intended to help prevent outbreaks of foodborne salmonellosis and listeriosis associated with imported enoki and wood ear mushrooms, and salmonellosis associated with bulb onions.

In July 2022, FDA unveiled an enhanced Enforcement Report Subscription Service for recalls that allows users, including industry and consumers, the option to receive notifications of new and updated recalls of FDA-regulated products posted to the application using custom keywords.

The U.S. Food and Drug Administration (FDA) has concluded its internal review of the agency’s response to the U.S. infant formula supply crisis, which details key findings and recommendations that will allow the agency to respond more quickly during food safety emergencies.

The U.S Food and Drug Administration (FDA) has completed a research study that evaluated Food Code recommendations for reducing the risk of norovirus in foodservice establishments.

The U.S. Food and Drug Administration (FDA) has announced that it will conduct targeted sampling of leafy greens as part of the Leafy Greens STEC Action Plan (LGAP). The agency also provided updates on the progress of LGAP and a summary report of a 2021 sampling assignment.

The Reagan-Udall Foundation has announced five members of its Independent Expert Panel who will evaluate the U.S. Food and Drug Administration’s (FDA’s) human foods program. The evaluation will launch September 8, 2022.

The U.S. Food and Drug Administration and its regulatory counterparts in Mexico—the Federal Commission for the Protection from Sanitary Risks and the National Service of Agro-Alimentary Health, Safety and Quality—recently held the second annual Food Safety Partnership Meeting.